reports
Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Drug-Delivery Syst...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Drug-Delivery System Improves Way Molecules Enter Bloodstream NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs.” To hear the AudioPressRelease, please visit: To view the full editorial, please visit: With each new study, the horizon of GLP-1’s therapeutic potential expands, painting a vibrant picture of a future where a single molecule could tackle a multitude of ...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of GLP-1 Agonists Through Proprietary Drug-Delivery Platform NEW YORK, Jan. 09, 2024 (GLOBE NEWSWIRE) -- via — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by ("NNW"), one of 60+ brands within the @ (), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, “Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs,” please visi...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Studies of Proprietary...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Studies of Proprietary Platform in Multibillion-Dollar GLP-1 Drug Space NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Can Diabetes, Weight-Loss Drugs Get Even Better?” To hear the AudioPressRelease, please visit: To view the full editorial, please visit: It shouldn’t be surprising that analysts at Markets and Research estimate the global diabetes drug market at $63.1 billion in 2021 on its way to $82.93 billion in 2027, while th...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating Proprietary Drug-De...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating Proprietary Drug-Delivery Platform for Improved Efficacy of GLP-1 Drugs NEW YORK, Oct. 31, 2023 (GLOBE NEWSWIRE) -- via — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by ("NNW"), one of 60+ brands within the @ (), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, “Can Diabetes, Weight-Loss Drugs Get Even Better?”,please visit: The prest...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Focused on Filling Need for Hy...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Focused on Filling Need for Hypertension Treatment Solution NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “The Power of Science to Stop a Killer.” To hear the AudioPressRelease, please visit: To view the full editorial, please visit: In its 2021 industry report, estimated the global anti-hypertensive drugs market at $24.17 billion in 2020 on its way to reach $27.81 billion in 2025. All told, hypertension costs the country on average ann...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Developing Powerful Tech to Tr...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Developing Powerful Tech to Treat Hypertension NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) -- via — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by ("NNW"), one of 50+ trusted brands within the (“IBN”), a multifaceted financial news and publishing company for private and public entities. To view the full publication, “The Power of Science to Stop a Killer,” please visit: Nearly half of all American adults suffer from hypertension (high blood pressure), often referred to as a silent killer. More ...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Stands as Global Leader in Del...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Stands as Global Leader in Delivery Tech Space NEW YORK, May 26, 2022 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Nicotine Surges as Smoking Sags.” To hear the AudioPressRelease, please visit: To view the full editorial, please visit: The fact remains that an estimated 1.1 billion people smoked cigarettes in 2019. According to stats from the World Health Organization, a stunning 780 million people said they want to quit. As a result, people look to a multitud...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Offers Breakthrough Delivery T...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Offers Breakthrough Delivery Tech in Hot Nicotine Space NEW YORK, May 25, 2022 (GLOBE NEWSWIRE) -- via — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by ("NNW"), one of 50+ trusted brands within the (“IBN”), a multifaceted financial news and publishing company for private and public entities. To view the full publication, “Nicotine Surges as Smoking Sags,” please visit: Seems like yesterday people were smoking cigarettes everywhere; many people still have memories of Grandpa puffing on his Ca...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Emerging as Leader in Pursuit ...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Emerging as Leader in Pursuit of More-Effective Hypertension Treatment NEW YORK, Sept. 16, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Hypertension: The Silent Killer Making Loud Noise for Investors.” To hear the AudioPressRelease, please visit: To view the full editorial, please visit: The market is certainly worth entering. Consider that Reportlinker.com estimates the global anti-hypertensive drugs market to be $24.37 billion in 2021 and growing 3.4% an...
Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Throw Hat into Hypertension ...
Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Throw Hat into Hypertension Ring with Proprietary Drug-Delivery System NEW YORK, Sept. 15, 2021 (GLOBE NEWSWIRE) -- via — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by ("NNW"), one of 50+ trusted brands within the (“IBN”), a multifaceted financial news and publishing company for private and public entities. To view the full publication, “Hypertension: The Silent Killer Making Loud Noise for Investors,” please visit: Hypertension, or high blood pressure, is rampant in America. An estimat...
Lexaria Bioscience Corp. (NASDAQ: LEXX) on Forefront of Exciting Hyper...
Lexaria Bioscience Corp. (NASDAQ: LEXX) on Forefront of Exciting Hypertension Innovation NEW YORK, Aug. 06, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Cardiovascular Disease Drug Market Offers Compelling Potential for First Movers, Innovators in the Space.” To hear the AudioPressRelease, please visit: To view the full editorial, please visit: Controlling blood pressure is essential to health. High blood pressure is a primary or contributing cause of death in almost 500,000 deaths a year, and...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Leads the Way in Innovating Hy...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Leads the Way in Innovating Hypertension Treatment NEW YORK, Aug. 04, 2021 (GLOBE NEWSWIRE) -- via — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by ("NNW"), one of 50+ trusted brands within the (“IBN”), a multifaceted financial news and publishing company for private and public entities. To view the full publication, “Cardiovascular Disease Drug Market Offers Compelling Potential for First Movers, Innovators in the Space,” please visit: One of the most pervasive diseases in first-world count...
Advantagewon Announces Private Placement of Units
Toronto, Ontario--(Newsfile Corp. - December 30, 2020) - Advantagewon Oil Corp. (CSE: AOC) (OTC: ANTGF), (the "Corporation", or "Advantagewon", or "AOC") is pleased to announce that it plans to complete a non-brokered private placement (the "Private Placement") of units ("Units" or each a "Unit") at a price of $0.0525 per Unit for aggregate gross proceeds of up to $750,000. Each Unit will be comprised of one common share in the capital of the Corporation (a "Common Share") and one Common Share purchase warrant (a "Warrant"). Each Warrant shall entitle the holder thereof to purchase one Common...
Advantagewon Oil Corp. Announces Completion of Share Consolidation
Toronto, Ontario--(Newsfile Corp. - December 18, 2020) - Advantagewon Oil Corp. (CSE: AOC) (OTC Pink: ANTGF), (the "Corporation", or "Advantagewon", or "AOC") is pleased to announce that it has completed its previously announced consolidation of its issued and outstanding common shares (the "Common Shares") on the basis of one (1) post-consolidation Common Share for twenty (20) pre-consolidation Common Shares (the "Consolidation"). Before Consolidation, the Company had 279,969,317 Common Shares issued and outstanding. Following completion of the Consolidation, the Corporation now has approxima...
Advantagewon Oil Corp. Announces Share Consolidation
Toronto, Ontario--(Newsfile Corp. - December 14, 2020) - Advantagewon Oil Corp. (CSE: AOC) (OTC Pink: ANTGF), (the "Corporation", or "Advantagewon", or "AOC") is pleased to announce that it will consolidate its issued and outstanding common shares (the "Common Shares") on the basis of one (1) post-consolidation Common Share for twenty (20) pre-consolidation Common Shares (the "Consolidation"). The Corporation received approval from its shareholders for the Consolidation at the Corporation's last annual general meeting (the "AGM") held on November 6, 2019. A consolidation on an up to 20:1 basis...
Advantagewon Oil Corp., Signs Definitive Agreement To Acquire a Signif...
Toronto, Ontario--(Newsfile Corp. - September 8, 2020) - Advantagewon Oil Corp. (CSE: AOC) (OTC PINK: ANTGF), (the "Corporation", "Advantagewon", "AOC") announced today that further to its press release dated May 22, 2020, it has signed the Definitive Agreement ("DA") to acquire all the issued and outstanding common shares of Groundstar Resources Limited (TSXV: GSA.H) ("GRL"). The transaction is to be structured as an amalgamation of AOC's wholly-owned subsidiary Opulence Resources Inc. and GRL, which has approximately $32,000,000 in accumulated tax losses and the acquisition of these losses ...
DGAP-News: Lexaria Bioscience Corp.: Lexaria Bioscience announces R&D ...
DGAP-News: Lexaria Bioscience Corp. / Key word(s): Agreement Lexaria Bioscience Corp.: Lexaria Bioscience announces R&D agreement with British American Tobacco 01.09.2020 / 07:47 The issuer is solely responsible for the content of this announcement. Lexaria Bioscience announces R&D agreement with British American Tobacco Kelowna, British Columbia- August 31, 2020 - Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that it has entered a research and development ("R&D") framework agree...
DGAP-News: Altria and Lexaria Conclude Phase I Research and Developmen...
DGAP-News: Lexaria Bioscience Corp. / Key word(s): Miscellaneous Altria and Lexaria Conclude Phase I Research and Development Program 16.07.2020 / 12:15 The issuer is solely responsible for the content of this announcement. Altria and Lexaria Conclude Phase I Research and Development Program R&D Program Utilized Lexaria's Patented DehydraTECHTM Technology for Oral Nicotine Delivery Conclusion of Phase I allows for additional phased private financings up to a further US$11 million from Altria KELOWNA, BC / ACCESSWIRE / July 16, 2020 / Lexaria Bioscience Corp. (OTCQX:...
Advantagewon Oil Corp., Acquires Additional Well
Toronto, Ontario--(Newsfile Corp. - July 14, 2020) - Advantagewon Oil Corp., (CSE: AOC), (OTC Pink: ANTGF), (the "Corporation", "Advantagewon", "AOC") announced today that it has acquired an additional oil well located in the Province of Alberta.The acquisition of this one well was for the purchase price of $1.00 CDN. The well is currently shut in and the Corporation plans on reactivating this well in the very near term. Prior to being shut in the well was producing approximately 10 BOPD.Stephen Hughes, CEO said, "We are very excited by this acquisition. This acquisition was made possible b...
Advantagewon Oil Corp., Completes Its Q1 Financial Statements
Toronto, Ontario--(Newsfile Corp. - June 22, 2020) - Advantagewon Oil Corp., (CSE: AOC), (OTC Pink: ANTGF), (the "Corporation", "Advantagewon", "AOC") announced today that as of the date of this press release, the Corporation had both completed and had filed onto SEDAR its Q1, 2020 Interim Financial Statements ("Interim Documents"). With the completion of the filing of the Interim Documents the Corporation is now current and up-to-date in its required filings and disclosures. As disclosed in the Corporation's April 22nd, 2020 press release, due to delays caused by COVID-19, the Corporation...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.